Morphology, oxygen vacancies, and other factors affecting the performance of supported bimetallic ceria catalysts.

Here in we report the development of a Pt-V/CeO2 catalyst performing under mild conditions in amide hydrogenation. Ceria with different morphologies was employed as support in this study. We further developed a glycol-thermal technique that yields thermally stable quantum dot ceria, which can be applied as a support. A systematic investigation revealed the importance of proximity between the small crystalline hydrogenating sites (Pt) and oxophilic sites (V). The study showed that oxygen vacancies on the ceria surface oxidize both Pt and V, poisoning the hydrogenation reaction. In contrast, the absence of oxygen vacancies promoted the hydrogenating ability of Pt sites and also improved their ability to participate in the H2 spillover mechanism and in situ formation of oxophilic V3+. This study demonstrates how the engineering of the oxygen vacancies on the surface of the redox support can manipulate the nature of active sites toward specific reactions.

Jumping from Fragment to Drug via Smart Scaffolds.

A focused drug repurposing approach is described where an FDA-approved drug is rationally selected for biological testing based on structural similarities to a fragment compound found to bind a target protein by an NMR screen. The approach is demonstrated by first screening a curated fragment library using 19 F NMR to discover a quality binder to ACE2, the human receptor required for entry and infection by the SARS-CoV-2 virus. Based on this binder, a highly related scaffold was derived and used as a "smart scaffold" or template in a computer-aided finger-print search of a library of FDA-approved or marketed drugs. The most interesting structural match involved the drug vortioxetine which was then experimentally shown by NMR spectroscopy to bind directly to human ACE2. Also, an ELISA assay showed that the drug inhibits the interaction of human ACE2 to the SARS-CoV-2 receptor-binding-domain (RBD). Moreover, our cell-culture infectivity assay confirmed that vortioxetine is active against SARS-CoV-2 and inhibits viral replication. Thus, the use of "smart scaffolds" based on binders from fragment screens may have general utility for identifying candidates of FDA-approved or marketed drugs as a rapid repurposing strategy. Similar approaches can be envisioned for other fields involving small-molecule chemical applications.

Proline N-oxides: modulators of the 3D conformation of linear peptides through "NO-turns".

Small peptides are essential mediators of numerous physiological processes. Consequently, there is huge interest in the de novo design of peptides with a predictable folding and related biological activity. In this study, we investigate the possibility of modulating the secondary structure of tetrapeptides through proline N-oxide moieties and N-methylation of the peptide backbone. A series of tetrapeptides were synthesised to investigate the combined effect of Pro N-oxide and N-methylation of the amide bond on the (n + 1) residue in terms of cis- and trans-isomerization, as well as how these modifications direct potential intramolecular hydrogen bonding interactions. The right combination of both these parameters led to a trans to cis-conformational interconversion and a change in the nature of the hydrogen bonding interactions, as demonstrated by NMR spectroscopic, molecular modeling analysis and thermal coefficient studies. Proline N-oxide residues were proposed to induce turns we named as NO-γ-turns and NO-ß-turns based on their similarity to traditional γ- and ß-turns.